Fundacion para la Investigacion Biomedica del Hospital Universitario Ramon y Cajal

Other

Pipeline Programs↗

Distinct drugs in development (Preclinical–Phase 3)

Indications↗

Distinct diseases across all programs

Clinical Trials↗

All sponsored trials (all statuses)

Activity

Recent Activity

Last 14 days

Sep 17, 2026

Completed

Amount, Distribution and Dysfunction of Body Fat as Determinants of Female Gonadal Dysfunction: From Functional Hypothalamic Amenorrhea to the Polycystic Ovary Syndrome

Sep 17, 2026

Active, not recruiting

Phase IV, Open-label, Single Arm, Multicenter Trial to Evaluate Pharmacokinetic Parameters of Peritoneal Diffusion and Peritoneal Diffusion Activity.

Sep 17, 2026

Completed

Efficacy and Safety of Fecal Microbiota Transfer (FMT) for Recurrent Urinary Tract Infections in Women

Earlier

Sep 4, 2026TrialPathogenesis of Functional Hyperandrogenism in Women With Type 1 Diabetes Mellitus: From Genetic-molecular Mechanisms to Clinical Phenotype.

Jun 24, 2026TrialMultimodal Approach to Sarcopenia and Its Prognostic Impact in Older Patients Hospitalized for Acute Heart Failure (MUSICA Study).

Jul 1, 2025TrialBrimonidine Eye Drops in the Prevention of Myopia Progression

May 30, 2025TrialAdministration of High Doses of Antiretroviral Drugs to Eliminate the Latent HIV-1 Reservoir

Jan 11, 2024TrialUse of Mesenchymal Stem Cells in Pre-term Patients With Bronchopulmonary Dysplasia.

4 more events

Sep 29, 2022TrialClinical Trial of Safety and Efficacy of Daily Application of Topical Dutasteride in Men With Androgenic Alopecia.

Apr 23, 2021TrialMicrobiota Transplant in Advanced Lung Cancer Treated With Immunotherapy

Nov 1, 2020TrialARTiBIOME: Observational Study on the Effect of HIV and ART on Gut Microbiome

Sep 18, 2020TrialClinical Trial of Pioglitazone Treatment in Patients With Type 2 Diabetes Mellitus and Covid-19

Details

Company Info

Company Overview

—

Mkt Cap

—

Revenue

—

Cash

Data sources: ClinicalTrials.gov (NIH) · OpenFDA (FDA) · ChEMBL (EMBL-EBI) · Open Targets (EBI/Sanger) · MedlinePlus (NIH) · PubMed (NIH) · SEC EDGAR (SEC)